PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Oner, A.* ; Kobold, S.

Transwell migration assay to interrogate human CAR-T cell chemotaxis.

STAR Protoc. 3:101708 (2022)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
A major impediment to effective cellular therapies in solid tumors is the limited access of therapeutic cells to the tumor site. One strategy to overcome this challenge is to endow T cells with chemotactic properties required to access tumor tissue. Here, we present a chimeric antigen receptor (CAR)-modified T cell strategy centered around enhanced T cell trafficking. We outline isolation, activation, and transduction of human T cells, as well as techniques for assessing migratory and cytotoxic capacity of CAR-T cells. For complete details on the use and execution of this protocol, please refer to Lesch et al. (2021).
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
0.000
0.000
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Biotechnology And Bioengineering ; Cancer ; Cell Isolation ; Cell-based Assays ; Immunology
Language english
Publication Year 2022
HGF-reported in Year 2022
e-ISSN 2666-1667
Journal STAR Protocols
Quellenangaben Volume: 3, Issue: 4, Pages: , Article Number: 101708 Supplement: ,
Publisher Elsevier
Publishing Place Radarweg 29, 1043 Nx Amsterdam, Netherlands
Reviewing status Peer reviewed
Institute(s) Unit for Clinical Pharmacology (KKG-EKLiP)
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-522100-001
Grants Hector Foundation
International Doctoral Program i-Target: Immunotargeting of Cancer - Elite Network of Bavaria
Melanoma Research Alliance Grants
Else Kroner-Fresenius-Stiftung
German Cancer Aid
Ernst-Jung-Stiftung
LMU Munich's Institutional Strategy LMUexcellent
Marie-Sklodowska-Curie Program Training Network for Optimizing Adoptive T Cell Therapy of Cancer - H2020 Program of the European Union
Go-Bio-initiative
M4 award - Bavarian Ministry of Economic Affairs
European Research Council
German Research Foundation (DFG)
Fritz-Bender Foundation
Wilhelm-Sander-Stiftung
Deutsche Jose-Carreras Leukamie Stiftung
Bundesministerium fur Bildung und Forschung
DOI 10.1016/j.xpro.2022.101708
WOS ID 001062185100007
Scopus ID 85138195219
PubMed ID 36136753
Erfassungsdatum 2022-11-21
[➜Report correction]